These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1779394)

  • 21. Surfactant replacement therapy.
    Yu V
    Indian Pediatr; 1998 Nov; 35(11):1081-96. PubMed ID: 10216542
    [No Abstract]   [Full Text] [Related]  

  • 22. [Evaluation of treating neonates with surfactants for respiratory distress syndrome. I. Importance of gas exchange].
    Gadzinowski J; Szymankiewicz M; Twarowska I; Halliday H
    Ginekol Pol; 1992; 63(3):101-4. PubMed ID: 1303908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On "A randomized, multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants" (Am J Perinatol 2004;21:109-120).
    Bancalari E
    Am J Perinatol; 2004 Jul; 21(5):307-9. PubMed ID: 15232767
    [No Abstract]   [Full Text] [Related]  

  • 24. Randomized trial comparing natural and synthetic surfactant: increased infection rate after natural surfactant?
    Kukkonen AK; Virtanen M; Järvenpää AL; Pokela ML; Ikonen S; Fellman V
    Acta Paediatr; 2000 May; 89(5):556-61. PubMed ID: 10852192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of severe respiratory distress syndrome with surfactant].
    Jacobsen T; Verder H; Skov L; Greisen GO; Friis-Hansen B
    Ugeskr Laeger; 1992 Jun; 154(23):1642-5. PubMed ID: 1631999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surfactant improves oxygenation in infants and children with pneumonia and acute respiratory distress syndrome.
    Herting E; Möller O; Schiffmann JH; Robertson B
    Acta Paediatr; 2002; 91(11):1174-8. PubMed ID: 12463314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Natural or synthetic surfactant in the treatment of neonatal respiratory distress syndrome].
    Robertson B; Saugstad OD
    Tidsskr Nor Laegeforen; 1994 Mar; 114(8):987-8. PubMed ID: 8191480
    [No Abstract]   [Full Text] [Related]  

  • 28. Evolution of pulmonary surfactants for the treatment of neonatal respiratory distress syndrome and paediatric lung diseases.
    Mazela J; Merritt TA; Gadzinowski J; Sinha S
    Acta Paediatr; 2006 Sep; 95(9):1036-48. PubMed ID: 16938747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exogenous surfactant in neonatal respiratory distress syndrome.
    Cashore WJ
    R I Med; 1995 Jan; 78(1):7-10. PubMed ID: 7873814
    [No Abstract]   [Full Text] [Related]  

  • 30. Use of surfactant for respiratory distress syndrome.
    Mallamo K
    Neonatal Netw; 1999 Oct; 18(7):43. PubMed ID: 10808888
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of preterm neonates with severe respiratory distress syndrome using exogenous natural surfactants of porcine origin].
    Valls i Soler A; López de Heredia I; Hernaéz Ortega E; Román Echevarría L; Gastiasoro Cuesta E; Robertson B
    An Esp Pediatr; 1992 May; 36(5):375-81. PubMed ID: 1616198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surfactant therapy: past, present and future.
    Speer CP; Sweet DG; Halliday HL
    Early Hum Dev; 2013 Jun; 89 Suppl 1():S22-4. PubMed ID: 23809343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulmonary mechanics in ventilated preterm infants with respiratory distress syndrome after exogenous surfactant administration: a comparison between two surfactant preparations.
    Choukroun ML; Llanas B; Apere H; Fayon M; Galperine RI; Guenard H; Demarquez JL
    Pediatr Pulmonol; 1994 Nov; 18(5):273-8. PubMed ID: 7898964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biophysical and physiological properties of a modified porcine surfactant enriched with surfactant protein A.
    Sun B; Curstedt T; Lindgren G; Franzén B; Alaiya AA; Calkovská A; Robertson B
    Eur Respir J; 1997 Sep; 10(9):1967-74. PubMed ID: 9311487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Biophysical models in investigations of exogenous surfactant activities on the surface tension and their theurapeutic effectiveness].
    Todorov R; Iordanova A; Georgiev GA; Petkova Kh; Stoimenova E; Georgieva R; Khristova E; Vasiliev Kh; Lalchev Z
    Akush Ginekol (Sofiia); 2007; 46 Suppl 1():29-36. PubMed ID: 18175392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Surfactant treatment of premature infants with respiratory distress syndrome].
    Saugstad OD; Gloppestad K
    Tidsskr Nor Laegeforen; 1990 Nov; 110(29):3737-41. PubMed ID: 2274941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Neonatal respiratory distress syndrome treated with a natural surfactant. The Norwegian Curosurf study].
    Saugstad OD; Danielsen K; Grønn M; Holt J; Meberg A; Silberg IE; Okland O
    Tidsskr Nor Laegeforen; 1993 Aug; 113(19):2389-93. PubMed ID: 8378900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebral and lung effects of a new generation synthetic surfactant with SP-B and SP-C analogs in preterm lambs.
    Rey-Santano C; Mielgo VE; Murgia X; Gomez-Solaetxe MA; Salomone F; Bianco F; Pelizzi N; Loureiro B; López de Heredia Y Goya J
    Pediatr Pulmonol; 2017 Jul; 52(7):929-938. PubMed ID: 28221717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surfactant treatment for acute respiratory distress syndrome.
    López-Herce J; de Lucas N; Carrillo A; Bustinza A; Moral R
    Arch Dis Child; 1999 Mar; 80(3):248-52. PubMed ID: 10325705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid improvement of static compliance after surfactant treatment in preterm infants with respiratory distress syndrome.
    Baraldi E; Pettenazzo A; Filippone M; Magagnin GP; Saia OS; Zacchello F
    Pediatr Pulmonol; 1993 Mar; 15(3):157-62. PubMed ID: 8327278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.